Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$376K Buy
3,107
+107
+4% +$12.4K 0.11% 100
2025
Q4
$318K Buy
3,000
+274
+10% +$25.7K 0.09% 101
2025
Q3
$230K Buy
+2,726
New +$225K 0.07% 103
2025
Q1
Sell
-2,210
Closed -$222K 114
2024
Q4
$222K Sell
2,210
-13,744
-86% -$1.42M 0.08% 103
2024
Q3
$1.82M Buy
15,954
+1,244
+8% +$148K 0.67% 50
2024
Q2
$1.83M Sell
14,710
-2,728
-16% -$351K 0.76% 42
2024
Q1
$2.31M Buy
17,438
+1,269
+8% +$156K 1.01% 28
2023
Q4
$1.76M Buy
16,169
+8
+0% +$830 0.83% 41
2023
Q3
$1.66M Sell
16,161
-359
-2% -$38.7K 0.91% 31
2023
Q2
$1.91M Sell
16,520
-1,075
-6% -$122K 1.05% 24
2023
Q1
$1.87M Buy
17,595
+1,068
+6% +$115K 1.1% 19
2022
Q4
$1.83M Buy
16,527
+1,178
+8% +$120K 1.26% 17
2022
Q3
$1.32M Buy
15,349
+575
+4% +$51.3K 0.97% 30
2022
Q2
$1.35M Sell
14,774
-197
-1% -$17.5K 1% 29
2022
Q1
$1.23M Buy
14,971
+351
+2% +$27.7K 0.78% 48
2021
Q4
$1.12M Buy
14,620
+1,497
+11% +$119K 0.71% 56
2021
Q3
$986K Buy
13,123
+1,635
+14% +$124K 0.72% 54
2021
Q2
$893K Sell
11,488
-498
-4% -$37K 0.69% 60
2021
Q1
$882K Buy
+11,986
New +$884K 0.82% 45

Other funds holding MRK

Alaethes Wealth's MRK Position: Q1 2026 in Review

Alaethes Wealth increased its Merck (MRK) stake by 3.6% in Q1 2026, buying an estimated $12.4K and bringing the position to 3,107 shares worth $376K. The position accounts for 0.11% of the portfolio, ranked #100.

Alaethes Wealth first reported a position in MRK in Q1 2021 and has held it in 19 quarters since. The position peaked at $2.31M in Q1 2024. 3,775 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Alaethes Wealth held 3,107 shares of Merck worth $376K as of Q1 2026.
  • Alaethes Wealth bought 107 Merck shares in Q1 2026, an estimated $12.4K.
  • Merck made up 0.11% of Alaethes Wealth's portfolio in Q1 2026, its #100 holding.
  • Alaethes Wealth first reported a position in Merck in Q1 2021 and has held it in 19 quarters since.
  • Alaethes Wealth's Merck position peaked at $2.31M in Q1 2024.
  • 3,775 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Alaethes Wealth's 13F filing for Q1 2026, filed 12 May 2026.